Journal of Fungi (Oct 2022)

The Case for Fungal Keratitis to Be Accepted as a Neglected Tropical Disease

  • Lottie Brown,
  • Guyguy Kamwiziku,
  • Rita O. Oladele,
  • Matthew J. Burton,
  • N. Venkatesh Prajna,
  • Thomas M. Leitman,
  • David W. Denning

DOI
https://doi.org/10.3390/jof8101047
Journal volume & issue
Vol. 8, no. 10
p. 1047

Abstract

Read online

Amongst the treatable cause of blindness among young people, fungal keratitis ranks high. There are an estimated 1,051,787 to 1,480,916 eyes affected annually, with 8–11% of patients having to have the eye removed. Diagnosis requires a corneal scraping, direct microscopy and fungal culture with a large number of airborne fungi implicated. Treatment involves the intensive application of antifungal eye drops, preferably natamycin, often combined with surgery. In low-resource settings, inappropriate corticosteroid eye drops, ineffective antibacterial therapy, diagnostic delay or no diagnosis all contribute to poor ocular outcomes with blindness (unilateral or bilateral) common. Modern detailed guidelines on fungal keratitis diagnosis and management are lacking. Here, we argue that fungal keratitis should be included as a neglected tropical disease, which would facilitate greater awareness of the condition, improved diagnostic capability, and access to affordable antifungal eye medicine.

Keywords